Importantly, Wu et al. [23] recently identified ADGRG6 as a prognostic biomarker that stabilizes mutant p53 and activates the EGFR/NF-κB signaling axis, promoting tumor cell proliferation in a tumor-intrinsic manner. The gene discussed is EGFR; the disease is neoplasm.